» Authors » R A deKemp

R A deKemp

Explore the profile of R A deKemp including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 311
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Crean A, Small G, Chow B, Ruddy T, Beanlands R, deKemp R
J Nucl Cardiol . 2022 Jun; 30(4):1709-1712. PMID: 35672566
No abstract available.
2.
Mc Ardle B, Leung E, Ohira H, Cocker M, deKemp R, DaSilva J, et al.
J Nucl Cardiol . 2013 Jan; 20(2):297-306. PMID: 23288545
Cardiac sarcoidosis (CS) has gained significant interest in recent years with the emergence of advanced imaging modalities such as MRI and F(18)-fluorodeoxyglucose-positron emission tomography (FDG-PET) as modalities to aid in...
3.
Klein R, Beanlands R, Wassenaar R, Thorn S, Lamoureux M, DaSilva J, et al.
Med Phys . 2010 Oct; 37(8):3995-4010. PMID: 20879561
Purpose: Factor analysis has been pursued as a means to decompose dynamic cardiac PET images into different tissue types based on their unique temporal signatures to improve quantification of physiological...
4.
Crawford S, Costford S, Aguer C, Thomas S, deKemp R, DaSilva J, et al.
Diabetologia . 2010 May; 53(9):1986-97. PMID: 20473479
Aims/hypothesis: AMP-activated protein kinase (AMPK) has a broad role in the regulation of glucose and lipid metabolism making it a promising target in the treatment of type 2 diabetes mellitus....
5.
Klein R, Adler A, Beanlands R, deKemp R
Conf Proc IEEE Eng Med Biol Soc . 2007 Feb; 2004:1393-6. PMID: 17271953
A rubidium-82 (/sup 82/Rb) elution system is described for use with clinical positron emission tomography. The system is self-calibrating with 1.4% repeatability, independent of generator activity and elution flow rate....
6.
Klein R, Adler A, Beanlands R, deKemp R
Phys Med Biol . 2007 Jan; 52(3):659-73. PMID: 17228112
A rubidium-82 ((82)Rb) elution system is described for use with positron emission tomography. Due to the short half-life of (82)Rb (76 s), the system physics must be modelled precisely to...
7.
Parkash R, deKemp R, Ruddy T, Kitsikis A, Hart R, Beauchesne L, et al.
J Nucl Cardiol . 2004 Aug; 11(4):440-9. PMID: 15295413
Background: Standard perfusion imaging may underestimate the extent of disease in 3-vessel coronary atherosclerosis. This study determined whether positron emission tomography quantification of perfusion reserve by use of rubidium 82...
8.
Vitale G, deKemp R, Ruddy T, Williams K, Beanlands R
J Nucl Med . 2001 Dec; 42(12):1730-6. PMID: 11752067
Unlabelled: In patients with non-insulin-dependent diabetes mellitus (NIDDM), FDG PET imaging is often problematic because of poor uptake of FDG. Different protocols have been used; however, these have not been...
9.
deKemp R, Ruddy T, Hewitt T, Dalipaj M, Beanlands R
J Nucl Med . 2000 Aug; 41(8):1426-35. PMID: 10945537
Unlabelled: Serial changes in myocardial perfusion may represent an important marker of disease progression or regression or the effects of therapy for patients with coronary artery disease (CAD). Quantitative methods...
10.
Abramson B, Ruddy T, deKemp R, Laramee L, Marquis J, Beanlands R
J Nucl Cardiol . 2000 Jul; 7(3):205-12. PMID: 10888390
Background: The diagnosis of coronary artery disease (CAD) in women continues to be a challenge. F-18 deoxyglucose (FDG) positron emission tomography (PET) has been used for detection of myocardial ischemia...